Leonilde Bonfrate1, Marcin Krawczyk, Antony Lembo, Ignazio Grattagliano, Frank Lammert, Piero Portincasa. 1. aDepartment of Biomedical Sciences and Human Oncology, Clinica Medica "A. Murri", Policlinico Hospital, University of Bari Medical School, Bari, Italy bDepartment of Medicine II, Saarland University Medical Center, Homburg, Germany cLaboratory of Metabolic Liver Diseases, Department of General, Transplant, and Liver Surgery, Medical University of Warsaw, Warsaw, Poland dDepartment of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA eItalian College of General Practitioners, Florence, Italy.
Abstract
OBJECTIVE: Fructose is absorbed by GLUT transporters in the small intestine. If this process is inadequate, abdominal symptoms because of fructose intolerance may arise. The effect of a tailored fructose-restricted diet on gastrointestinal complaints was assessed in patients with fructose intolerance. MATERIALS AND METHODS: Following an abnormal fructose breath test (50 g), 107 patients (64 also with lactose intolerance) entered three study periods: weeks 0-32 (free diet), weeks 32-36 (progressive increasing amount of fructose up to quantity inducing symptoms, 'trigger dose'), and weeks 36-48 (tailored fructose-restricted diet according to the 'trigger dose'). A subgroup of 15 patients underwent additional fructose breath tests (35, 25 g) to compare three different doses. RESULTS: At baseline, the most frequent symptoms were bloating and abdominal pain, and were more severe with combined fructose and lactose intolerance. During the free diet, patients reported eliminating (48%) or reducing (52%) fructose-containing foods, with a significant improvement in symptoms (abdominal pain from 79.7 ± 1.3 to 19.3 ± 1.8 mm; bloating from 83.1 ± 1.3 to 19.4 ± 1.8 mm; number of evacuations/day from 3.9 ± 0.16 to 1.1 ± 0.04; Bristol score from 5.1 ± 0.14 to 3.8 ± 0.1, P < 0.00001). During the tailored fructose-restricted diet, the consistent improvement in symptoms persisted and was similar to the improvement on free diet (abdominal pain 23.6 ± 1.9 mm; bloating 19.4 ± 1.8 mm; number of evacuations/day 1.7 ± 0.07; Bristol score 3.5 ± 0.06, P<0.00001 vs. baseline). A dose-dependent effect of fructose was observed on symptoms during the fructose breath test. CONCLUSION: In our setting, individuals with fructose intolerance show an inappropriate dietary self-management. By contrast, a tailored fructose-restricted diet improves gastrointestinal symptoms without senseless food deprivation.
OBJECTIVE:Fructose is absorbed by GLUT transporters in the small intestine. If this process is inadequate, abdominal symptoms because of fructose intolerance may arise. The effect of a tailored fructose-restricted diet on gastrointestinal complaints was assessed in patients with fructose intolerance. MATERIALS AND METHODS: Following an abnormal fructose breath test (50 g), 107 patients (64 also with lactose intolerance) entered three study periods: weeks 0-32 (free diet), weeks 32-36 (progressive increasing amount of fructose up to quantity inducing symptoms, 'trigger dose'), and weeks 36-48 (tailored fructose-restricted diet according to the 'trigger dose'). A subgroup of 15 patients underwent additional fructose breath tests (35, 25 g) to compare three different doses. RESULTS: At baseline, the most frequent symptoms were bloating and abdominal pain, and were more severe with combined fructose and lactose intolerance. During the free diet, patients reported eliminating (48%) or reducing (52%) fructose-containing foods, with a significant improvement in symptoms (abdominal pain from 79.7 ± 1.3 to 19.3 ± 1.8 mm; bloating from 83.1 ± 1.3 to 19.4 ± 1.8 mm; number of evacuations/day from 3.9 ± 0.16 to 1.1 ± 0.04; Bristol score from 5.1 ± 0.14 to 3.8 ± 0.1, P < 0.00001). During the tailored fructose-restricted diet, the consistent improvement in symptoms persisted and was similar to the improvement on free diet (abdominal pain 23.6 ± 1.9 mm; bloating 19.4 ± 1.8 mm; number of evacuations/day 1.7 ± 0.07; Bristol score 3.5 ± 0.06, P<0.00001 vs. baseline). A dose-dependent effect of fructose was observed on symptoms during the fructose breath test. CONCLUSION: In our setting, individuals with fructose intolerance show an inappropriate dietary self-management. By contrast, a tailored fructose-restricted diet improves gastrointestinal symptoms without senseless food deprivation.
Authors: Agostino Di Ciaula; Gabriella Garruti; Gema Frühbeck; Maria De Angelis; Ornella de Bari; David Q-H Wang; Frank Lammert; Piero Portincasa Journal: Curr Med Chem Date: 2019 Impact factor: 4.530
Authors: Piero Portincasa; Giuseppe Celano; Nadia Serale; Paola Vitellio; Francesco Maria Calabrese; Alexandra Chira; Liliana David; Dan L Dumitrascu; Maria De Angelis Journal: Nutrients Date: 2022-06-15 Impact factor: 6.706
Authors: Carlo Giuseppe Rizzello; Piero Portincasa; Marco Montemurro; Domenica Maria Di Palo; Michele Pio Lorusso; Maria De Angelis; Leonilde Bonfrate; Bernard Genot; Marco Gobbetti Journal: Nutrients Date: 2019-12-04 Impact factor: 5.717
Authors: Giusy Rita Caponio; Michele Pio Lorusso; Giovanni Trifone Sorrenti; Vincenzo Marcotrigiano; Graziana Difonzo; Elisabetta De Angelis; Rocco Guagnano; Agostino Di Ciaula; Giusy Diella; Antonio Francesco Logrieco; Maria Teresa Montagna; Linda Monaci; Maria De Angelis; Piero Portincasa Journal: Nutrients Date: 2020-03-28 Impact factor: 5.717
Authors: Bandar Mohammed Bardisi; Abdulaziz Kamal H Halawani; Hassan Kamal H Halawani; Aseel Hassan Alharbi; Nesma Saleh Turkostany; Taraji Saeed Alrehaili; Aisha Ahmad Radin; Nasser Moqbil Alkhuzea Journal: J Family Med Prim Care Date: 2018 Sep-Oct